𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection

✍ Scribed by Oliver Waidmann; Verena Bihrer; Bernd Kronenberger; Stefan Zeuzem; Albrecht Piiper; Nicole Forestier

Book ID
119230042
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
329 KB
Volume
44
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Caspase activation is required for antiv
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection
✍ Xandra Volkmann; Markus Cornberg; Heiner Wedemeyer; Frank Lehner; Michael P. Man πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 239 KB πŸ‘ 1 views

Only half of patients with chronic hepatitis C virus (HCV) infection and genotype-1 show a sustained antiviral response to the current antiviral therapy. The reason this treatment fails is unclear, and no reliable marker exists that predicts the treatment outcome. In the present study, we investigat

Is serum uric acid a predictive factor o
Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
✍ Rinaldo Pellicano; Giovanni Puglisi; Alessia Ciancio; Federico Balzola; Giorgio πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 87 KB

## Abstract Several factors, including metabolic profile, are predictive of response to standard antiviral therapy in patients with chronic hepatitis C. In a retrospective study, it was investigated whether uric acid, involved in metabolic syndrome, could be included. A total of 153 patients (56.2%